Alyeska Investment Group
PHVS icon

Alyeska Investment Group’s Pharvaris PHVS Stock Holding History

Alyeska Investment Group’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.53M Hold
125,000
– – 0.01% 510
2025
Q4 		$3.47M Hold
125,000
– – 0.01% 487
2025
Q3 		$3.12M Buy
+125,000
New +$2.77M 0.01% 489

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Alyeska Investment Group's PHVS Position: Q1 2026 in Review

Alyeska Investment Group held its Pharvaris (PHVS) position steady in Q1 2026 at 125,000 shares worth $3.53M. The position accounts for 0.01% of the portfolio, ranked #510.

Alyeska Investment Group first reported a position in PHVS in Q3 2025 and has held it in 3 quarters since. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • Alyeska Investment Group held 125,000 shares of Pharvaris worth $3.53M as of Q1 2026.
  • Alyeska Investment Group left its Pharvaris share count unchanged in Q1 2026.
  • Pharvaris made up 0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #510 holding.
  • Alyeska Investment Group first reported a position in Pharvaris in Q3 2025 and has held it in 3 quarters since.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.